Abstract:T-cell acute lymphoblastic leukemia (ALL) accounts for 15% of pediatric ALL cases and is associated with early relapse and inferior outcome. The poorer prognosis of T-ALL compared to B-precursor ALL may in part reflect the lack of unique features on which to base therapy. NOTCH1 mutations are of particular interest since these were reported in 37-71% of T-ALLs. The prognostic value of NOTCH1 mutations remains controversial as both favorable and unfavorable associations were reported, whereas in other studies there were no associations between NOTCH1 mutations and treatment outcome. NOTCH1 is a potentially attractive therapeutic target for T-ALL since constitutively activating effects of mutant NOTCH1 can be abolished with gamma secretase inhibitors (GSIs). Because of possible effects of GSIs on other cellular targets in addition to NOTCH1, we explored shRNA knockdown of NOTCH1 to identify novel NOTCH1-regulated genes that may serve as prognostic indicators or therapeutic targets in T-ALL. NOTCH1 expression was knocked down in Jurkat T-ALL cells using lentivirus expressing shRNAs for NOTCH1 or a non-targeted control (NTC) sequence. NOTCH1 knockdown was verified using western blots to measure activated NOTCH1 (ICN1) protein levels, and real-time RT-PCR (qPCR) to measure transcript levels of known NOTCH1 targets (e.g., HES1). Two clonal sublines (J.2-4 and J.2-7) were identified with significantly decreased expression of NOTCH1 compared to NTC. The J.2-4 and J.2-7 sublines showed minimal changes in cell growth, cell cycle progression and apoptosis. To characterize genotypic changes accompanying NOTCH1 knockdown, we performed microarray analysis with Agilent Whole Genome oligonucleotide microarrays and microRNA (miR) HumanV2 arrays. The miR array identified 20 miRs in J.2-4 and J.2-7 cells with altered expression compared to NTC greater than 1.5-fold (p Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4360.

The notch pathway promotes NF-κB activation through Asb2 in T cell acute lymphoblastic leukemia cells

Notch-1 Regulates Akt Signaling Pathway and the Expression of Cell Cycle Regulatory Proteins Cyclin D1, CDK2 and P21 in T-ALL Cell Lines

Notch1 Signaling is Involved in Regulating Foxp3 Expression in T-ALL.

SIRT1 Regulates the Phosphorylation and Degradation of P27 by Deacetylating CDK2 to Promote T-cell Acute Lymphoblastic Leukemia Progression.

Data from Stabilization of Notch1 by the Hsp90 Chaperone is Crucial for T-Cell Leukemogenesis

The truncate mutation of Notch2 enhances cell proliferation through activating the NF-κB signal pathway in the diffuse large B-cell lymphomas.

Silencing of Notch3 Using Shrna Driven by Survivin Promoter Inhibits Growth and Promotes Apoptosis of Human T-cell Acute Lymphoblastic Leukemia Cells.

Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia

A Regulatory Loop Involving Notch and Wnt Signaling Maintains Leukemia Stem Cells in T-Cell Acute Lymphoblastic Leukemia

The NF-κB1/p50 Subunit Influences the Notch/IL-6-Driven Expansion of Myeloid-Derived Suppressor Cells in Murine T-Cell Acute Lymphoblastic Leukemia

NOTCH1 Transcriptionally Activates Deptor and Promotes AKT Activation in Acute T-Cell Lymphoblastic Leukemia

MAFB Enhances Oncogenic Notch Signaling in T Cell Acute Lymphoblastic Leukemia.

Interconnecting Molecular Pathways in the Pathogenesis and Drug Sensitivity of T-cell Acute Lymphoblastic Leukemia

Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress

Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia

Notch1 is Required for Hypoxia-Induced Proliferation, Invasion and Chemoresistance of T-cell Acute Lymphoblastic Leukemia Cells

Notch1 Mutations In T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance And Implication In Multifactorial Leukemogenesis

Downregulating Notch Signaling in KrasG12D/+ Mice Inhibits Both T-Cell Leukemia and Myeloproliferative Neoplasm in a Cell-Autonomous Manner

RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway

ARRB1-Induced NOTCH1 Degradation Is Inhibited By Mir-223 in T-ALL

Abstract 4360: Loss of NOTCH1 is associated with decreased expression of hsa-miR-125a-5p in T-cell acute lymphoblastic leukemia: Implications for using NOTCH1 inhibition in chemotherapy